Equity Overview
Price & Market Data
Price: $2.25
Daily Change: $0.00 / 0.00%
Range: $2.25 - $2.31
Market Cap: $226,597,504
Volume: 2,799
Performance Metrics
1 Week: 0.90%
1 Month: -14.77%
3 Months: 11.39%
6 Months: -63.71%
1 Year: -55.09%
YTD: -28.34%
Company Details
Employees: 83
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R, which has completed Phase 2 clinical trial for the treatment of Thyroid Eye Disease (TED). Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California.